# Oriza Ventures

> Oriza Ventures is a Silicon Valley venture capital firm founded in 2015 by John Yu and Alex Liang. It backs early-stage technology companies, primarily in the United States and North America, and offers founders operating experience and networks in Silicon Valley and China. Its portfolio has included Zingbox, Peer5, Parade, Unifimoney and SyntheX.

- **Founded:** 2015
- **Headquarters:** San Jose, United States
- **Founders:** John Yu (Co-Founder and Founding Partner), Alex Liang (Co-Founder and Founding Partner)
- **Products:** Early-stage venture investment, Founder and business development support, Private venture fund management
- **Notable:** Portfolio company Zingbox was acquired by Palo Alto Networks in September 2019 following an announced $75 million cash agreement., Portfolio company Peer5 was acquired by Microsoft in August 2021., Participated in Parade’s $12.7 million Series A announced in February 2022.

## Products & services

- **Early-stage venture investment** — Equity financing for seed and early-stage technology businesses, primarily in the United States and North America.
- **Founder and business development support** — Operating guidance and introductions drawing on the partners’ entrepreneurial backgrounds and Silicon Valley and China networks.
- **Private venture fund management** — Management of Oriza Ventures Technology Fund, L.P. and Oriza Ventures Technology Fund II, LP.

## Achievements

- Portfolio company Zingbox was acquired by Palo Alto Networks in September 2019 following an announced $75 million cash agreement.
- Portfolio company Peer5 was acquired by Microsoft in August 2021.
- Participated in Parade’s $12.7 million Series A announced in February 2022.
- Participated in Unifimoney’s $10 million seed round announced in April 2022.

## Latest updates

- **2026-04** — The April 1 Form ADV identifies San Jose as the principal office and reports $134,373,364 in private fund assets; the adviser reports under exempt reporting status.
- **2024-01** — Caplight reports Oriza participation in a SyntheX Series A. This is a secondary database record rather than a company announcement.
- **2022-10** — Oriza-backed SyntheX announced a Bristol Myers Squibb research collaboration with up to $550 million in contingent milestones plus royalties; those milestones were not upfront cash.

## Links

- Website: https://www.orizaventures.com/
- LinkedIn: https://www.linkedin.com/company/oriza-ventures
- Twitter/X: https://twitter.com/OrizaVentures
- Facebook: https://www.facebook.com/Oriza-Ventures-1668710816720916/

---

Profile page: https://yespress.io/oriza-ventures
Published by YesPress — https://yespress.io
Last updated: 2026-10-27